Surgical Science Sweden AB Stock: price and insider trades · Sweden

Headquartered in Gothenburg, Sweden, Surgical Science Sweden AB belongs to the Health Care sector and traces its origins to 1999. Filings by its managers are published through Finansinspektionen. Over the twelve months to 30 October 2026, 7 filings were filed, from 5 insiders.

Not one open-market sale was filed. On the buying side, 3 insiders reported 5 purchases totalling €1.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 board member, 1 finance chief and 1 chief executive. The largest single trade was a purchase of €758k by Thomas Eklund, published on 28 November 2025.

Compared with its exchange (1,034 companies, median 9 filings), a count of 7 filings is below the norm. The full history, which starts in 2017, counts 19 purchases against 19 sales.

In the case of 2 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 12 December 2025, 331 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.